5613294 BASELINE PATIENT CHARACTERISTICS FROM A UK EARLY ACCESS TO MEDICINES SCHEME (EAMS) WITH VOXELOTOR, A HBS POLYMERIZATION INHIBITOR, FOR THE TREATMENT OF HEMOLYTIC ANEMIA DUE TO SICKLE CELL DISEASE

5613294 BASELINE PATIENT CHARACTERISTICS FROM A UK EARLY ACCESS TO MEDICINES SCHEME (EAMS) WITH VOXELOTOR, A HBS POLYMERIZATION INHIBITOR, FOR THE TREATMENT OF HEMOLYTIC ANEMIA DUE TO SICKLE CELL DISEASE

Bibliographic Details
Main Authors: P. Eleftheriou, J. Sharif, R. Kesse-Adu, M. Filian-Gloor, A. Agrawal, G. Barcelos, P. Telfer
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000928248.83702.ec

Internet

http://journals.lww.com/10.1097/01.HS9.0000928248.83702.ec

Similar Items